The FDA Endocrinologic and Metabolic Drugs Advisory Committee has recommended for approval Teplizumab, a humanized anti-CD3 monoclonal antibody shown in a randomized clinical trial to delay...

We are learning how immune cells naturally clear the body of senescent cells that contribute to aging and many chronic diseases. Understanding this process may open new ways of treating age-related...

Adélaïde Bernard, a graduate student in the Metabolic Biology program at UC Berkeley at Vaisse lab in Diabetes Center, was awarded first place in the 2021 Berkeley Grad Slam for her presentation...

Beatson Qizhi Tang and Gregory Ku have been named two-of-the five recipients of the 2021 "Passion to Find a Cure" Award, which provides grants for outstanding biomedical researchers in Type 1 Diabetes...

Diabetes Center's James Lee, MD, has been named a recipient of the 2021 Parker Institute for Cancer Immunotherapy Early Career Researchers awards, along with five other exceptional scholars from UCSF...